{"title":"Dos diagnósticos aos manuais: mercado farmacêutico e transtornos mentais da infância em questão","authors":"Marcia da Silva Mazon","doi":"10.5007/2175-7984.2020.E75323","DOIUrl":null,"url":null,"abstract":"The purpose of the article is to situate the moment of change – both in articles and in research procedures – that marks DSM-III as a way of approaching psychiatric disorders, placing the pharmaceutical industry in the making of new discourses. This is the moment for the reemergence of Attention Deficit Hyperactivity Disorder (ADHD) and marks the confrontation with the Freudian psychodynamic approach that will be supported by the alternative of tests and statistical procedures. What is the context of these changes? We mobilize authors from economic sociology to think of the drug market as a field of struggle – struggle around the criteria for classifying reality – as well as the dynamics of interaction with the field of health. The article starts from bibliographic research and document analysis. The argument is that the nosology of ADHD, like any other cultural arbitrary, is not neutral and expresses power relations. If several researches point to medical power as biopolitical power, it is possible to see how new arrangements between the pharmaceutical industry and psychiatry expand the scope of the first to reach adolescence and childhood, adding the role of the pharmaceutical industry as biopolitical reinforcement","PeriodicalId":47847,"journal":{"name":"Politics & Society","volume":"19 1","pages":"115-140"},"PeriodicalIF":4.1000,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Politics & Society","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.5007/2175-7984.2020.E75323","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"POLITICAL SCIENCE","Score":null,"Total":0}
引用次数: 3
Abstract
The purpose of the article is to situate the moment of change – both in articles and in research procedures – that marks DSM-III as a way of approaching psychiatric disorders, placing the pharmaceutical industry in the making of new discourses. This is the moment for the reemergence of Attention Deficit Hyperactivity Disorder (ADHD) and marks the confrontation with the Freudian psychodynamic approach that will be supported by the alternative of tests and statistical procedures. What is the context of these changes? We mobilize authors from economic sociology to think of the drug market as a field of struggle – struggle around the criteria for classifying reality – as well as the dynamics of interaction with the field of health. The article starts from bibliographic research and document analysis. The argument is that the nosology of ADHD, like any other cultural arbitrary, is not neutral and expresses power relations. If several researches point to medical power as biopolitical power, it is possible to see how new arrangements between the pharmaceutical industry and psychiatry expand the scope of the first to reach adolescence and childhood, adding the role of the pharmaceutical industry as biopolitical reinforcement
期刊介绍:
Politics & Society is a peer-reviewed journal. All submitted papers are read by a rotating editorial board member. If a paper is deemed potentially publishable, it is sent to another board member, who, if agreeing that it is potentially publishable, sends it to a third board member. If and only if all three agree, the paper is sent to the entire editorial board for consideration at board meetings. The editorial board meets three times a year, and the board members who are present (usually between 9 and 14) make decisions through a deliberative process that also considers written reports from absent members. Unlike many journals which rely on 1–3 individual blind referee reports and a single editor with final say, the peers who decide whether to accept submitted work are thus the full editorial board of the journal, comprised of scholars from various disciplines, who discuss papers openly, with author names known, at meetings. Editors are required to disclose potential conflicts of interest when evaluating manuscripts and to recuse themselves from voting if such a potential exists.